Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy
https://doi.org/10.18008/1816-5095-2012-4-65-68
Abstract
Purpose: to evaluate the efficacy of agent Hylomax-Сomod in the postoperative period of Laser Epithelial Keratomileusis (LASEK).
Methods: In 60 eyes (30 patients) was performed excimer laser vision correction by LASEK. According to study patients were randomized into 2 groups. Patients of the Group I have been treated by the standard protocol of medical support. Patients of the Group II along with the standard regimen were recieved Hylomax-Сomod.
Results: On the 2nd day after the excimer laser correction for 63.3% had patients of Group I had complete epithelialization of the ablation zone, the rest — a slight defect in the optical zone that recovered for 3-4 days. In Group II 80% of patients was determined by complete epithelialization of the ablation zone, the remaining 20% of patients went to a slight defect in the third day, which is 17% lower than that of patients in group I.
Conclusion: Hylomax-Сomod promotes rapid healing of the ablation zone, reduce the risk of complications.
About the Authors
S. A. Korotkich
ГБОУ ВПО Уральская государственная медицинская академия Минздравсоцразвития России, Екатеринбург
Russian Federation
Russian Federation
A. S. Shamkin
ГБОУ ВПО Уральская государственная медицинская академия Минздравсоцразвития России, Екатеринбург
Russian Federation
Russian Federation
References
1. Егоров В. В., Дутчин И. В., Смолякова Г. П., Сорокин Е. Л. Клинико‐патогенети- ческая эффективность иммуномодуляции у пациентов с риском регенера- торных нарушений после коррекции миопии методами ФРК и ЛАСИК // Реф- ракционная хирургия и офтальмология. — 2007. — Т. 7, No 3. — С. 18‐24.
2. Либман Е. С., Шахова Е. В. Слепота и инвалидность по зрению в России // Те- зисы докладов 8‐го съезда офтальмологов России. — М., 2005. — С. 78‐79.
3. Смиренная Е. В., Князева С. В., Арутюнова О. В. Комплексное восстановитель- ное лечение у пациентов с миопией высокой степени после эксимерлазер- ной коррекции // Рефракционная хирургия и офтальмология. — 2008. — Т. 8, No 3. — С. 16‐20.
4. Brewitt H., Polzer H. Medikamentose Therapie destrockenen Auges // Brewitt H., Zierhut M. Trockenes Auge. Heidelberg: «Kaden» / 2001. — S. 169‐182.
5. Kim K. H., Oh J., Kim J. H., Kim H. M. Bacteria — filtering effect of a filtering sys- tem used in eye drops // J. Korean Ophthalmol. Soc. — 2007. — V. 48, No 10. — P.
6. ‐1334.
7. Sand B. B., Marner K., Norn M. S. Sodium hyaluronate in the treatment of kerato-
8. conjunctivitis sicca. A double masked clinical trial // Acta Ophthalmol. — 1989. — V. 67, No 2. — P. 181‐183.
Review
For citations:
Korotkich S.A., Shamkin A.S. Laser Epithelial Keratomileusis: Hylomax-Сomod as effective agent of accessory therapy. Ophthalmology in Russia. 2012;9(4):65-68. (In Russ.) https://doi.org/10.18008/1816-5095-2012-4-65-68
Views:
988
Email this article 